Concepedia

Calvin Q. Pan

CQ

Statistics

Publications

60

Citations

4.4K

H-Index

28

Active since

2005

Affiliations

NYU Langone Health(Current)

Capital Medical University

New York University

Beijing Ditan Hospital

Icahn School of Medicine at Mount Sinai

Calvin Q. Pan is an author at NYU Langone Health specializing in hepatitis, viral hepatitis, and medicine.

ORCID

Top concepts

Publications per year

2005–2025

60

Publications

60

Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load

Calvin Q. Pan, Zhongping Duan, Erhei Dai et al. · New England Journal of Medicine · 2016 · 562 citations · Full text

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Edward Gane, Wai Kay Seto, Henry Lik‐Yuen Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 535 citations

, , +9

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 406 citations · Full text

, , +10

Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers

H. Zou, Yunliu Chen, Zhongping Duan et al. · Journal of Viral Hepatitis · 2011 · 363 citations

Natural History and Clinical Consequences of Hepatitis B Virus Infection

Calvin Q. Pan, Jin X. Zhang · International Journal of Medical Sciences · 2005 · 199 citations · Full text

Rows per page

1–5 of 60